Scottsdale Clinic Pairs Esketamine with TMS for Rapid Depression Relief

Scottsdale TMS Therapy, a mental health clinic in Arizona, has introduced FDA-approved Spravato (esketamine) nasal spray for adults with treatment-resistant depression. The clinic pairs this fast-acting therapy with existing TMS (transcranial magnetic stimulation) protocols to address complex mood disorders at a neurological level. Esketamine works by targeting NMDA receptors to promote neuroplasticity, offering relief within days compared to the weeks required by conventional antidepressants. This combination provides a lifeline for patients who have failed multiple medication trials, potentially reducing suicidal ideation and restoring cognitive flexibility.

As a REMS-certified clinic, Scottsdale TMS Therapy ensures rigorous safety protocols, including pre-treatment screenings, supervised administration, and a two-hour monitoring period. The facility offers a comfort-focused environment with Apollo TMS chairs, private rooms, an on-site cafe, and an outdoor patio. The clinic accepts most insurance plans and handles authorization internally to improve access. For confidential consultations, diagnostic evaluations, and same-day insurance verification, patients can contact Scottsdale TMS Therapy.

The clinic, specializing in board-certified psychiatric care, also provides medication management for depression, anxiety, and OCD. By integrating esketamine with TMS, the clinic aims to break the cycle of pharmaceutical adjustments and offer a more targeted approach to severe mood disorders. This innovation addresses a critical gap in mental health care, providing hope for those who have not found relief through standard treatments.